This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

G. F. WEINFELD, M.D.; M. COOPERSTOCK, M.D.

Am J Dis Child. 1929;38(1):35-46.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The value of diphtheria toxoid (anatoxin-Ramon), the modified toxin of diphtheria, in active immunization of man has been firmly established since Glenny's experiments with animals and Ramon's clinical demonstration of its efficiency. Its use on a broad scale has grown, particularly in France and in Canada. The lack of any extensive trial of toxoid in this country is, to a large extent, attributable to the strong foothold that prophylaxis with toxin-antitoxin has gained, following the impetus given to its popularization by Park and his collaborators. Through their laudable efforts, a marked reduction in the incidence of diphtheria has been effected in this country.

The preference that toxoid has received in other countries within the last few years is the result of certain important advantages that have been recognized in the use of this material. These advantages have been emphasized by Ramon and Helie¹ in a recent report to the . . . [Full Text PDF of this Article]

Author Affiliations
ANN ARBOR, MICH.

From the Department of Pediatrics and Infectious Diseases, University of Michigan Medical School.

Footnotes
Submitted for publication, Feb. 2, 1929.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?